Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism

Table 1 Differentially expressed transcripts (up-regulated)

Name	Normalized intensity		CV		Log2 (Ratio)	P value
	HSEC	TEC	HSEC	TEC	TEC/HSEC	TEC/HSEC
hsa-miR-1	68.257645	186.191599	0.029597	0.068251	1.447725	0.000086
hsa-miR-3127-5p	131.708413	205.954953	0.021898	0.041495	0.644981	0.000128
hsa-miR-3146	126.901537	261.084309	0.090416	0.054737	1.040806	0.000266
hsa-miR-3198	115.365033	179.95054	0.020914	0.063584	0.641394	0.000680
hsa-miR-3673	71.141771	126.901537	0.023094	0.050363	0.834941	0.000125
hsa-miR-4701-5p	494.146893	744.766395	0.047938	0.083445	0.591848	0.002918

There are 6 miRNAs with increased expression in hepatocellular carcinoma TECs. Selection criteria to identify differentially expressed genes are established at log2|Fold change| ≥ 0.585 and P < 0.05. HSECs: Hepatic sinusoidal endothelial cells; TECs: Tumor endothelial cells.